dihydrotestosterone has been researched along with 2019 Novel Coronavirus Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 9 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganesh, SK; Hunker, KL; Kanthi, Y; Knight, JS; Kumar, N; Obi, AT; Yalavarthi, S; Zuo, Y | 1 |
| Akıncı, E; Bal, C; Erel, Ö; Eser, F; Güner, R; Hasanoglu, İ; Kalem, AK; Kayaaslan, B; Sezer, S; Yılmaz, G | 1 |
| Adamcova, K; Duskova, M; Horackova, L; Hornova, M; Kolatorova, L; Parizek, A; Simkova, M; Vaisova, V; Vitku, J; Vosatkova, M | 1 |
| Bailey, KR; Ballinger, BA; Chaudry, IH; Ganesh, R; Goswami, J; Heller, SF; Hurt, RT; Loomis, EA; Lundell, KA; MacArthur, TA; Park, MS; Price-Troska, TL; Ramachandran, D; Salonen, BR; Spears, GM; Stephens, D | 1 |
| Kamalov, AA; Mareev, VY; Mareev, YV; Mershina, EA; Nesterova, OY; Ohobotov, DA; Orlova, IA; Pavlova, ZS; Plisyk, AG; Samokhodskaya, LM; Strigunov, AA; Tsurskaya, DD; Yu L, B | 1 |
| Wadman, M | 1 |
| Afshari, A; Azarpira, N; Janfeshan, S; Roozbeh, J; Yaghobi, R | 1 |
| Atsumi, T; Cho, KY; Inoshita, N; Kamada, K; Kameda, H; Kenmotsu, Y; Konno, S; Miyoshi, H; Nakakubo, S; Nakamura, A; Nakamura, J; Nomoto, H; Sawamura, Y; Shimatsu, A; Sugino, H; Suzuki, M; Takahashi, Y; Yamashita, Y; Yuno, A | 1 |
| Basnet, J; Huffman, AM; Rezq, S; Romero, DG; Yanes Cardozo, LL | 1 |
1 review(s) available for dihydrotestosterone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.
Topics: Aged; Angiotensin-Converting Enzyme 2; COVID-19; Dihydrotestosterone; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Male; Oncogene Proteins, Fusion; Prostatic Neoplasms; Receptors, Androgen; SARS-CoV-2; Serine Endopeptidases; Signal Transduction; Spike Glycoprotein, Coronavirus; Transcription, Genetic; Virus Internalization | 2021 |
8 other study(ies) available for dihydrotestosterone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism.
Topics: Angiotensin Receptor Antagonists; Cell Adhesion Molecules; Cells, Cultured; COVID-19; Dihydrotestosterone; Endothelium, Vascular; Female; Humans; Inflammation; Male; SARS-CoV-2; Sex Characteristics; Spike Glycoprotein, Coronavirus; Spironolactone; Tumor Necrosis Factor-alpha; Valsartan | 2021 |
COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Aldosterone; Androstenedione; Androsterone; Chromatography, Liquid; Corticosterone; Cortodoxone; COVID-19; Dehydroepiandrosterone Sulfate; Desoxycorticosterone; Dihydrotestosterone; Estradiol; Estrone; Humans; Hydrocortisone; Pregnenolone; Progesterone; Severity of Illness Index; Tandem Mass Spectrometry | 2022 |
COVID-19, Vaccination, and Female Fertility in the Czech Republic.
Topics: 20-alpha-Dihydroprogesterone; Androgens; Animals; Anti-Mullerian Hormone; COVID-19; COVID-19 Vaccines; Czech Republic; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Female; Fertility; Follicle Stimulating Hormone; Humans | 2022 |
Estradiol and Dihydrotestosterone Levels in COVID-19 Patients.
Topics: Adult; COVID-19; Dihydrotestosterone; Estradiol; Female; Humans; Male; Middle Aged; Testosterone | 2023 |
[Androgenic status of men with severe COVID-19: the role of testosterone and dihydrotestosterone [within the program FOUNDER (features of a new coronavirus infection course and options therapy depending on the androgenic status)]].
Topics: Androgens; Anti-Inflammatory Agents; COVID-19; Dihydrotestosterone; Humans; Male; Testosterone | 2023 |
Sex hormones signal why virus hits men harder.
Topics: Androgen Antagonists; Coronavirus Infections; COVID-19; Dihydrotestosterone; Humans; Male; Pandemics; Pneumonia, Viral; Prostatic Neoplasms; Sex Factors; Testosterone; Treatment Outcome | 2020 |
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Amides; Benzamidines; Combined Modality Therapy; COVID-19; Dihydrotestosterone; Disease Progression; Female; Guanidines; Health Personnel; Heparin; Humans; Japan; Metyrapone; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pregnenediones; Pyrazines; SARS-CoV-2; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Body Weight; Cathepsin L; COVID-19; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Kidney; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; SARS-CoV-2; Serine Endopeptidases; Up-Regulation; Virus Internalization | 2021 |